Like other weight loss injections, the medication will be supplied in a pre-filled pen designed for self-administration
Success on the scale increases a hunger for more success, increasing motivation
In the STEP-4 (Effect and Safety of Semaglutide 2.4 mg Once-Weekly in Subjects With Overweight or Obesity Who Have Reached Target Dose During Run-in Period) trial, 16 participants who discontinued semaglutide after 20 weeks regained a mean 6.9% of their baseline body weight over 48 weeks
MET inhibitors combined with immunotherapy show strong therapeutic potential
Clinical, cosmetic and investigational dermatology, 147-153
Additional experimental data support the protective role of GLP-1, including improved outcomes in DPP-4 knockout rats exposed to endotoxins and reduced mortality following GLP-1R activation (Perl et al., 2018